Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Bladder Cancer | The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer

Bladder Cancer | The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer

Aug 13, 2020

Featuring perspectives from Drs Arjun Balar, Siamak Daneshmand, Ashish M Kamat and Jonathan E Rosenberg on the following topics:

  • Introduction (00:00)
  • Immune checkpoint inhibitors for non-muscle-invasive urothelial bladder cancer (UBC) (4:17)
  • Immune checkpoint inhibitors as neoadjuvant/adjuvant therapy for muscle-invasive UBC (25:42)
  • Immune checkpoint inhibitors in advanced UBC (35:28)
  • Current and future roles of recently FDA-approved novel therapies (51:02)

CME information and select publications